# First Western Financial Inc: financial statements, quarterly

MYFW · Nasdaq · CIK 1327607 · [Financials](/sectors/financials.md)

Pages: [Overview](/companies/myfw.md) · [Financials](/companies/myfw/financials.md) · [Filings](/companies/myfw/filings.md) · [Insiders](/companies/myfw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/myfw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [22.5](/filings/0001327607-24-000183.md) | [13.9 d](/filings/0001327607-25-000020.md) | [23.3](/filings/0001327607-25-000053.md) | [20.4](/filings/0001327607-25-000118.md) | [22.0](/filings/0001628280-25-047822.md) | [24.3 d](/filings/0001628280-26-012825.md) | [24.7](/filings/0001628280-26-029340.md) | [22.4](/filings/0001628280-26-051423.md) | [24.0](/filings/0001628280-25-047822.md) | [25.7 d](/filings/0001628280-26-012825.md) | [28.3](/filings/0001628280-26-029340.md) | [28.6](/filings/0001628280-26-051423.md) |
| Interest expense | $m | [19.7](/filings/0001327607-24-000183.md) | [21.7 d](/filings/0001327607-25-000020.md) | [22.3](/filings/0001327607-25-000053.md) | [22.3](/filings/0001327607-24-000163.md) | [22.5](/filings/0001327607-24-000183.md) | [21.2 d](/filings/0001327607-25-000020.md) | [19.8](/filings/0001327607-25-000053.md) | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.1](/filings/0001327607-24-000183.md) | [(1.1) d](/filings/0001327607-25-000020.md) | [1.1](/filings/0001327607-25-000053.md) | [0.3](/filings/0001327607-25-000118.md) | [0.5](/filings/0001628280-25-047822.md) | [1.2 d](/filings/0001628280-26-012825.md) | [1.2](/filings/0001628280-26-029340.md) | [0.8](/filings/0001628280-26-051423.md) | [0.8](/filings/0001628280-25-047822.md) | [1.1 d](/filings/0001628280-26-012825.md) | [1.9](/filings/0001628280-26-029340.md) | [1.7](/filings/0001628280-26-051423.md) |
| Net income | $m | [3.1](/filings/0001327607-24-000183.md) | [(3.2) d](/filings/0001327607-25-000020.md) | [2.5](/filings/0001327607-25-000053.md) | [1.1](/filings/0001327607-25-000118.md) | [2.1](/filings/0001628280-25-047822.md) | [2.7 d](/filings/0001628280-26-012825.md) | [4.2](/filings/0001628280-26-029340.md) | [2.5](/filings/0001628280-26-051423.md) | [3.2](/filings/0001628280-25-047822.md) | [3.3 d](/filings/0001628280-26-012825.md) | [6.2](/filings/0001628280-26-029340.md) | [5.7](/filings/0001628280-26-051423.md) |
| Diluted EPS | $ per share | [0.32](/filings/0001327607-24-000183.md) | not reported | [0.26](/filings/0001327607-25-000053.md) | [0.11](/filings/0001327607-25-000118.md) | [0.22](/filings/0001628280-25-047822.md) | not reported | [0.43](/filings/0001628280-26-029340.md) | [0.26](/filings/0001628280-26-051423.md) | [0.32](/filings/0001628280-25-047822.md) | not reported | [0.63](/filings/0001628280-26-029340.md) | [0.57](/filings/0001628280-26-051423.md) |
| Basic EPS | $ per share | [0.33](/filings/0001327607-24-000183.md) | not reported | [0.26](/filings/0001327607-25-000053.md) | [0.11](/filings/0001327607-25-000118.md) | [0.22](/filings/0001628280-25-047822.md) | not reported | [0.43](/filings/0001628280-26-029340.md) | [0.26](/filings/0001628280-26-051423.md) | [0.33](/filings/0001628280-25-047822.md) | not reported | [0.64](/filings/0001628280-26-029340.md) | [0.59](/filings/0001628280-26-051423.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [3,003](/filings/0001327607-24-000183.md) | [2,975](/filings/0001327607-25-000020.md) | [2,932](/filings/0001327607-25-000053.md) | [2,938](/filings/0001327607-25-000118.md) | [2,912](/filings/0001628280-25-047822.md) | [2,919](/filings/0001628280-26-012825.md) | [2,906](/filings/0001628280-26-029340.md) | [3,027](/filings/0001628280-26-051423.md) | [3,240](/filings/0001628280-25-047822.md) | [3,155](/filings/0001628280-26-051423.md) | [3,241](/filings/0001628280-26-029340.md) | [3,238](/filings/0001628280-26-051423.md) |
| Total liabilities | $m | [2,756](/filings/0001327607-23-000170.md) | [2,733](/filings/0001327607-25-000020.md) | [2,687](/filings/0001327607-24-000092.md) | [2,691](/filings/0001327607-24-000163.md) | [2,663](/filings/0001327607-24-000183.md) | [2,667](/filings/0001628280-26-012825.md) | [2,650](/filings/0001327607-25-000053.md) | [2,768](/filings/0001327607-25-000118.md) | [2,979](/filings/0001628280-25-047822.md) | [2,889](/filings/0001628280-26-051423.md) | [2,967](/filings/0001628280-26-029340.md) | [2,957](/filings/0001628280-26-051423.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001327607-25-000020.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [246](/filings/0001327607-24-000183.md) | [243](/filings/0001628280-26-012825.md) | [246](/filings/0001327607-25-000118.md) | [247](/filings/0001628280-25-047822.md) | [249](/filings/0001628280-25-047822.md) | [252](/filings/0001628280-26-051423.md) | [257](/filings/0001628280-26-051423.md) | [259](/filings/0001628280-26-051423.md) | [261](/filings/0001628280-25-047822.md) | [266](/filings/0001628280-26-051423.md) | [273](/filings/0001628280-26-051423.md) | [281](/filings/0001628280-26-051423.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [14.7 d](/filings/0001327607-24-000183.md) | [11.8 d](/filings/0001327607-25-000020.md) | [(2.3)](/filings/0001327607-25-000053.md) | [(11.5) d](/filings/0001327607-25-000118.md) | [18.8 d](/filings/0001628280-25-047822.md) | [(4.4) d](/filings/0001628280-26-012825.md) | [8.0](/filings/0001628280-26-029340.md) | [(9.1) d](/filings/0001628280-26-051423.md) | [10.0 d](/filings/0001628280-25-047822.md) | [(10.8) d](/filings/0001628280-26-012825.md) | [15.3](/filings/0001628280-26-029340.md) | [12.2 d](/filings/0001628280-26-051423.md) |
| Capital expenditure | $m | [0.5 d](/filings/0001327607-24-000183.md) | [0.5 d](/filings/0001327607-25-000020.md) | [0.2](/filings/0001327607-25-000053.md) | [0.4 d](/filings/0001327607-25-000118.md) | [0.3 d](/filings/0001628280-25-047822.md) | [0.4 d](/filings/0001628280-26-012825.md) | [1.0](/filings/0001628280-26-029340.md) | [0.6 d](/filings/0001628280-26-051423.md) | [1.1 d](/filings/0001628280-25-047822.md) | [1.3 d](/filings/0001628280-26-012825.md) | [0.6](/filings/0001628280-26-029340.md) | [0.9 d](/filings/0001628280-26-051423.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001327607-25-000020.md) | [0.0](/filings/0001327607-25-000053.md) | [0.0 d](/filings/0001327607-25-000118.md) | [0.1 d](/filings/0001628280-25-047822.md) | [0.0 d](/filings/0001628280-26-012825.md) | [0.0](/filings/0001628280-26-029340.md) | [0.5 d](/filings/0001628280-26-051423.md) | [0.3 d](/filings/0001628280-25-047822.md) | [0.0 d](/filings/0001628280-26-012825.md) | [0.1](/filings/0001628280-26-029340.md) | [0.0 d](/filings/0001628280-26-051423.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [9,673](/filings/0001327607-23-000170.md) | [9,733](/filings/0001327607-24-000092.md) | [9,686](/filings/0001327607-24-000163.md) | [9,743](/filings/0001327607-24-000183.md) | [9,711](/filings/0001327607-25-000053.md) | [9,751](/filings/0001327607-25-000118.md) | [9,767](/filings/0001628280-25-047822.md) | [9,799](/filings/0001628280-26-029340.md) | [9,809](/filings/0001628280-26-051423.md) | [9,869](/filings/0001628280-25-047822.md) | [9,900](/filings/0001628280-26-029340.md) | [9,949](/filings/0001628280-26-051423.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,765,129 at 2026-07-29, from the cover of the [10-Q filed 2026-07-31](/filings/0001628280-26-051423.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.